Welcome To Our Company

We cross reference to the clients specific illness or ailment. This calculated recommendation is followed up by referring the client to the nearest dispensary or clinic. We will have a dedicated mobile app and a desktop app. Our technology is proprietary. We have accumulated a huge database of strains, cannabinoids, and medicinal applications. Our management and advisory team is involved in pain management, computers, neuroscience and technology.

Major voting updates as of November 8, 2016 show 7 additional states including California, Florida and Massachusetts have legalized medical and recreational marijuana. The developments could lead to additional 7 to 8 billion in annual sales, or double the estimates to 36 billion by 2020. President-Elect Trump, is "in favor of medical marijuana 100%." Effectively legalizing medical cannabis at the national level would allow physicians the ability to write prescriptions for marijuana, and it would open the floodgates to medical research into pot, granting easier access to researchers, universities, and drug companies. Trump has always supported states rights to chose their own pathway to legalized marijuana.

See what we provide for your health

Dr. Michael Stern


Michael Stern graduated from medical school in 1973 and since 1983 has been a board-certified urologist and urological surgeon. Dr. Stern served as an adjunct clinical faculty member at Bast-yr University School of Naturopathic Medicine for 11 years (1995 --2006). Dr. Stern operates the Northwest Healthy Options Clinic in Seattle, Washington. Dr. Stern continues advising patients on lifestyle issues and alternative healthy treatments for a wide variety of diseases, including medical cannabis.

Dr. Bindiya Moorjani


Dr. Bindiya Moorjani was a awarded a Ph. D. in biomedical sciences from the Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York University. Dr. Moorjani has authored several scientific studies that have been published in scientific journals. She did major studies on Serotonin. From 1993 through 1999, Dr. Moorjani was a graduate researcher at the Mount Sinai School of Medicine in the doctoral program concentrating on neurobiology.